Page 147 - Livre électronique des RFTP 2023
P. 147

P95.CLINICAL, SPIROMETRIC AND THERAPEUTIC PROFIL
               OF FREQUENT EXACERBATORS IN COPD


               W.  BENZARTI,  F.DABBEBI,  A.KNAZ,  B.BENBDIRA,  I.GARGOURI,  O.TABKA,  S.AISSA,
               A.ABELGHANI

               SERVICE DE PNEUMOLOGIE CHU FARHAT HACHED DE SOUSSE, TUNISIE

               INTRODUCTION : Chronic obstructive pulmonary disease (COPD) is a frequent yet
               underestimated chronic inflammatory disease. It is a major public health problem
               due to its high morbidity and mortality. Acute exacerbation (AE) of COPD is a fatal
               event, leading to poor outcomes among COPD patients frequent exacerbator.

               This study aimed to describe the frequent exacerbator phenotype in patients with
               COPD.

               METHODS:  This is a retrospective descriptive study of patients who had presented
               at least  two COPD  AEs  during one  year of follow-up; in  the Pneumology
               Department at Farhat Hached Hospital of Sousse, Tunisia.


               RESULTS: A total of277 patients were enrolled in this study The mean age was 67
               years with extremes ranging from 41 to 89 years, and 87.7% of the patients male ;
               43.6 % of the patients were current smokers and 46.5% were ex-smokers.44% had at
               least one comorbidity associated with COPD. Dyspnea was the major symptom;
               patients were classified as stage 2 and 3 respectively in 41.2% and 43.7% of cases.
               NAs for the frequency of AE per patients per year was 2, 94 with extremes ranging
               from 2 to 10 ; and 74% of the patients had presented at least one COPD AE requiring
               hospitalization.

               The  mean FEV1 was  1,115 ml  (41.63%) pre-bronchodilation and 1,221  ml  (42.59%)
               post-bronchodilation and the subjects were classified  as follows: GOLD 1 (7.2%),
               GOLD 2 (19.9%), GOLD 3 (41.5%), GOLD 4 (31 ,4%).
               It was noted that 24.5% of our frequent exacerbators were on ICS while 7.9% were
               on  a double long-acting bronchodilator and  only 9.4%  were  on  inhaled triple
               therapy.

               CONCLUSION : The frequent exacerbator phenotype among patients with COPD
               is a particular  entity,  with distinct characteristics, requiring  standardized
               management.



















                                                                                             145 | P ag e
   142   143   144   145   146   147   148   149   150   151   152